SC 13G Filing

Company

ARS Pharmaceuticals, Inc.

Filed

January 4, 2021

Accession Number

0000935836-21-000008

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →